Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia.

Published in: Journal of medical economics (2021)

In patients with TD, treatment with valbenazine is highly cost-effective compared with deutetrabenazine.

Keyphrases